H7617

Provides that where the administration, use, or maintenance of epinephrine within schools and on buses is authorized, this use includes epinephrine delivery devices approved by the United States Food & Drug Administration and epinephrine nasal sprays.

Chamber Passed·5/28/26

Rhode Island H7617 allows schools and buses to use epinephrine auto-injectors and nasal sprays for emergencies.

Rhode Island H7617 amends school health policies to allow the use of epinephrine auto-injectors and nasal sprays for treating anaphylaxis in schools and on buses. The bill ensures that school personnel are not liable for ordinary negligence in administering epinephrine. It also mandates that schools provide training for bus drivers and monitors in epinephrine administration and requires parental consent for epinephrine use. The act takes effect upon passage.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the House · 63–0 · May 28
Current
Health and Human Services Committee
Next
Session adjourned — paused until it reconvenes

Sponsors

DDDDDDD
7
0
Democratic CaucusRepublican Caucus

Roll Call Votes

63 Yea

DDDDDDRDDDRDRDDDDDRDDDDDDDDDDIDDDDDDDDRDDDDDDRDDDRDDRDDRDDDDDDD

0 Nay

12 Not Voting

DDDDDDDDDRDD

Calendar

May 19

12:00 AM

House Education Consideration

Mar 17

12:00 AM

House Education Hearing

History

Jun 9

Senate

Referred to Senate Health and Human Services

May 28

House

House passed Sub A

May 22

House

Placed on House Calendar (05/28/2026)